Human Papillomavirus vaccine is especially indicated in all IEIs with increased susceptibility to HPV including DOCK8 deficiency, Ataxia Telangiectasia, Netherton syndrome, Wiskott Aldrich syndrome STK4 and CD40 ligand deficiency [113]. This evidence concerns the gene DOCK8 and hyperinsulinemic hypoglycemia, familial, 4.